Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nuclcard.2024.102070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Benefit of 82-Rubidium Positron Emission Tomography for risk stratification in a patient with Intrapericardial diaphragmatic hernia.
J Nucl Cardiol
November 2024
Department of Nuclear Medicine, Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, United Kingdom.
82-rubidium positron emission tomography determined myocardial flow reserve and outcomes following cardiac revascularisation - A multicentre registry study.
Int J Cardiol
June 2024
Copenhagen University Hospital, Bispebjerg and Frederiksberg, Department of Cardiology, Denmark.
Background: Finding patients with chronic coronary syndromes (CCS) whom revascularization could benefit, is complicated. Myocardial flow reserve (MFR), a measurement of myocardial perfusion, has proven prognostic value on survival and risk of major adverse cardiac events (MACE). We investigated if MFR identifies who may benefit from revascularization.
View Article and Find Full Text PDFPosition emission tomography can picture the distribution of flow tracers as well as of metabolic substrates or analogs. Studies of the distribution of these tracers allow to infer information about regional myocardial clearance (flow X extraction) and substrate utilization. In a study of 32 patients after myocardial infarction, we have contrasted flow and substrate utilization to demonstrate ischemic but viable myocardium in the arterial territory of the infarct in a number of patients also specially after fibrinolytic reperfusion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!